OxyContin's maker is accused of fueling the opioid epidemic. Its new overdose antidote was just fast-tracked by the FDA
The US Food and Drug Administration granted Purdue Pharma's experimental opioid overdose drug fast-track designation. According to Purdue, its drug, nalmefene hydrochloride injection, has a longer effect than naloxone, another opioid antagonist that is approved to reverse overdoses.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
More News: Epidemics | Epidemiology | Food and Drug Administration (FDA) | Health | Overdose | Oxycodone | OxyContin | Pharmaceuticals